Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-RAS status for unresectable colorectal liver metastasis (BECK study): Long-term results of survival.
Masayuki OkunoEtsuro HatanoRei TodaHiroto NishinoKojiro NakamuraTakamichi IshiiSatoru SeoKojiro TauraKentaro YasuchikaTakefumi YazawaMasazumi ZaimaAkiyoshi KanazawaHiroaki TerajimaSatoshi KaiharaYukihito AdachiNaoya InoueKatsuyoshi FurumotoDai ManakaAtsuo TokukaHiroaki FuruyamaKoji DoiTetsuro HiroseTakahiro HorimatsuSuguru HasegawaShigemi MatsumotoYoshiharu SakaiShinji UemotoPublished in: Journal of hepato-biliary-pancreatic sciences (2020)
Conversion hepatectomy achieved a similar long-term survival to the results of previous studies in initially resectable patients, although many of them experienced several post-hepatectomy recurrences. Left-sided primary was found to be the predictor for conversion hepatectomy.